Articles

Consultation on low value turnover exemption (LVT) scheme

The amendments made to the Therapeutic Goods Act 1989 (the Act) by the Therapeutic Goods Amendment (2013 Measures No. 1) Act 2014 commenced on 28 February 2014.

The TGA reviewed studies on tartrazine, a yellow colouring used in medicines, and found it safe when properly labelled, with no strong evidence of harm like allergies or behavioural issues.

Pilot web service for transmission of adverse event reports from medical software to the Therapeutic Goods Administration

The Australian government will introduce a comprehensive package of reforms for Australia's Therapeutic Goods Administration (TGA) to ensure the regulation of medicines and medical devices is more effective and transparent.

The TGA intends to cancel all pain-killers containing dextropropoxyphene - Capadex, Di-Gesic, Doloxene and Paradex - from the Australian Register of Therapeutic Goods (ARTG), from 1 March 2012.

The Australian Customs and Border Protection Service and the Therapeutic Goods Administration have taken part in an international ‘Week of Action’ targeting the online sale of counterfeit and illegal medicines.

Contrary to media reports today, the TGA has not approved the use of Nembutal by Dr Nitschke.

The Australian Government today released the report of the Therapeutic Goods Administration (TGA) Transparency Review panel, chaired by Professor Dennis Pearce.

Eight synthetic cannabis-like substances will be classified as prohibited substances throughout Australia from 8 July, Parliamentary Secretary for Health and Ageing, Catherine King, has announced.

Landmark agreement to achieve world standards in therapeutic products
media release, The Hon Julia Gillard MP - Prime Minister of Australia

Professor John Horvath has reviewed the use of influenza vaccines in Australia and our system for reporting adverse events following vaccination.

Australian consumers and health professionals will have more ready access to generic medicines following the passage of legislation through the Senate today.

Therapeutic Goods Administration

The Australian community's access to authoritative information about the safety of medicines and medical devices will be greatly enhanced with the launch today of a revamped Therapeutic Goods Administration (TGA) website.

On 4 May 2011 the TGA is going to launch its new corporate website.

Australia's medicines regulator, the Therapeutic Goods Administration, has today issued precautionary advice to doctors not to give patients a second dose of the vaccine Pneumovax 23 pending completion of an investigation into an increased rate of adverse events in people receiving the vaccine for the second time.

TGA is conducting a panel-led review to explore ways to improve transparency and public engagement in its regulatory work.

The Therapeutic Goods Administration (TGA) officially launched a new organisational structure on 1 July 2010.

The Therapeutic Goods Administration (TGA) has approved an extension to the shelf life for Tamiflu (oseltamivir) from five to seven years, when stored below 25°C. This extension is effective from 1 May 2009.